Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Male breast cancer is a rare disease, accounting for only 1% of breast cancer diagnoses in
the USA. The current literature suggests that genetic factors including BRCA2 mutations …

Background Male breast cancer (MBC) is a rare disease for which there is limited
understanding of treatment patterns and prognostic factors. Methods Men with TNM stage I …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Objective To investigate the in vitro anticancer effect of Aloe vera (A. vera) and Calligonum
comosum (C. comosum) extracts against hepatocellular carcinoma (HepG2) cells. Methods …

Background Cancer is currently the leading cause of death globally and the number of
deaths from cancer is on the rise daily. Medicinal plants have been in continuous use over …

Male breast cancer is a rare disease for which treatment has been based on the evidence
available from female breast cancer. The new genomic tools can better characterize the …

National Comprehensive Cancer Network (NCCN) guidelines for female breast cancer
treatment and surveillance are well established, but similar guidelines on male breast …

Background: The 21-gene recurrence score (RS) assay is retrospectively validated for
assessing prognosis and benefit from chemotherapy in hormone receptor–positive, early …

Gene expression assays are widely used to predict risk of recurrence in early breast cancer
(BC). We report the 21‐gene expression assay (Oncotype Dx) recurrence score (RS) …